Publication
Date | SPC No. | SPC
Category | Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
|---|
25 February 2015
(Journal 6562)
| SPC/GB00/014 | Expired | Applicants: SANOFI-AVENTIS DEUTSCHLAND GMBH and General Hospital Corporation
Bruningstrasse 50, 65929 Frankfurt am Main, Germany
Product: Etanercept
Product Type: Medicinal
Authorised: CH 55365 1 February 2000
UK EU/1/99/126/001 3 February 2000
Authorised Extension:
Patent No: EP0464533
Title: Fusion proteins with parts of immunoglobulins, their production and use
SPC No: SPC/GB00/014
Date Expired: 31 January 2015 |
25 February 2015
(Journal 6562)
| SPC/GB00/018 | Expired | Applicant: AbbVie Deutschland GmbH & Co KG
Max-Planck-Ring 2a, 65205 Wiesbaden, GERMANY
Product: Etanercept
Product Type: Medicinal
Authorised: UK EU/1/99/126/001 3 February 2000
Authorised Extension:
Patent No: EP0471701
Title: Novel TNF-inhibiting proteins and their preparation
SPC No: SPC/GB00/018
Date Expired: 31 January 2015 |
25 February 2015
(Journal 6562)
| SPC/GB02/011 | Expired | Applicant: Genzyme Corporation
One Kendall Square, Cambridge, Massachusetts 02139, USA
Product: Sevelamer
Product Type: Medicinal
Authorised: UK EU/1/99/120/001-004 2 February 2000
Authorised Extension:
Patent No: EP0716606
Title: Phosphate-Binding Polymers for Oral Administration
SPC No: SPC/GB02/011
Date Expired: 1 February 2015 |
25 February 2015
(Journal 6562)
| SPC/GB06/015 | Expired | Applicants: Jeffrey S Rubin and Paul W Finch and Stuart A Aaronson
2020 Baltimore Road, Apt.K-44, Rockville, MD 20851, USA
Product: Palifermin
Product Type: Medicinal
Authorised: UK EU/1/05/314/001 25 October 2005
Authorised Extension:
Patent No: EP0555205
Title: DNA encoding a growth factor specific for epithelial cells
SPC No: SPC/GB06/015
Date Expired: 29 January 2015 |
25 February 2015
(Journal 6562)
| SPC/GB07/080 | Extensions Granted | Applicant: Georgetown University
37th and O Streets, N.W. Washington, DC 20057, USA
Product: The recombinant L1 protein of Human Papillomavirus type 16
Product Type: Medicinal
Authorised: UK EU/1/06/358/001 20 September 2006
Authorised Extension: Gardasil:EU/1/06/357/001-008 & EU/1/06/357/018-021 C(2011) 8513 of 16/11/11 EMEA/H/C/703/II/WS/29 Silgard:EU/1/06/358/001-008 & EU/1/06/358/018-021 C(2011)8237 of 10/11/11 EMEA/H/C/732/WS/29
Patent No: EP0647140
Title: Papillomavirus vaccines
SPC No: SPC/GB07/080
Date Extension Granted: 29 January 2015
Extension Expires On: 23 December 2018 |
25 February 2015
(Journal 6562)
| SPC/GB15/007 | Lodged | Applicant: Idexx Laboratories, Inc.
One Idexx Drive, Westbrook, Maine 04092, USA
Product: A combination of florfenicol or a pharmaceutically acceptable ester thereof, terbinafine or a pharmaceutically acceptable salt thereof and betamethasone or a pharmaceutically acceptable ester thereof.
Product Type: Medicinal
Authorised: UK EU/2/14/170 1 August 2014
Authorised Extension:
Patent No: EP1781256
Title: Phospholipid gel compositions for drug delivery and methods of treating conditions using same
SPC No: SPC/GB15/007
Date Lodged: 28 January 2015 |
25 February 2015
(Journal 6562)
| SPC/GB15/008 | Lodged | Applicant: AbbVie Bahamas Ltd.
Sassoon House, Shirley Street & Victoria Ave, New Providence, Nassau, Bahamas
Product: Dasabuvir, in all forms protected by the basic patent
Product Type: Medicinal
Authorised: UK EU/1/14/983 15 January 2015
Authorised Extension:
Patent No: EP2203431
Title: Anti-infective Pyrimidines and uses thereof
SPC No: SPC/GB15/008
Date Lodged: 30 January 2015 |
25 February 2015
(Journal 6562)
| SPC/GB15/009 | Lodged | Applicant: Eli Lilly and Company
Corporation Centre, Indianapolis, Indiana 46285, USA
Product: Dulaglutide
Product Type: Medicinal
Authorised: UK EU/1/14/956/001 -002 25 November 2014
Authorised Extension:
Patent No: EP1641823
Title: GLP-1 Analog Fusion Proteins
SPC No: SPC/GB15/009
Date Lodged: 29 January 2015 |
